Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Vaccine|November 22, 2008
Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 yearsTino F Schwarz, Marek Spaczynski, Achim Schneider, et al.Human Vaccines & Immunotherapeutics|June 16, 2015
Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents--A single blind randomized trialNoris Pavia-Ruz, Katia Abarca, Alejandro Lepetic, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 29, 2007
Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvantCourt Pedersen, Tiina Petaja, Gitte Strauss, et al.The Journal of Pathology|December 1, 2011
One virus, one lesion--individual components of CIN lesions contain a specific HPV typeWim Quint, David Jenkins, Anco Molijn, et al.Vaccine|February 14, 2016
Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in ChinaRongcheng Li, Chang Gui Li, Yanping Li, et al.Scientific Reports|October 11, 2019
Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell linesMargaretha A Skowron, Patrick Petzsch, Karin Hardt, et al.The Pediatric Infectious Disease Journal|October 27, 2004
A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritisBeatrice De Vos, Timo Vesikari, Alexandre C Linhares, et al.Human Vaccines|December 16, 2010
Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccineTino F Schwarz, Mariëlle Kocken, Tiina Petäjä, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 24, 2010
Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine: a randomized, controlled trial in adolescent girlsDoris M Rivera Medina, Alejandra Valencia, Alet de Velasquez, et al.The Pediatric Infectious Disease Journal|September 9, 2005
Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infantsBélen Salinas, Irene Pérez Schael, Alexandre C Linhares, et al.Pageof 4